Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftQuality of Life Research
Vol/bind26
Udgave nummerSuppl. 1
Sider (fra-til)56-57
ISSN0962-9343
StatusUdgivet - okt. 2017
Begivenhed24th Annual Conference of the International Society for Quality of Life Research, - Philadelphia, USA
Varighed: 18. okt. 201721. okt. 2017

Konference

Konference24th Annual Conference of the International Society for Quality of Life Research,
LandUSA
ByPhiladelphia
Periode18/10/201721/10/2017

Citationsformater